Francesca Ricci Selected Research

Shiga Toxins (Vero Toxin)

1/2020	Particulate Shiga Toxin 2 in Blood is Associated to the Development of Hemolytic Uremic Syndrome in Children.
1/2019	The structure of the Shiga toxin 2a A-subunit dictates the interactions of the toxin with blood components.
10/2011	Change in conformation with reduction of alpha-helix content causes loss of neutrophil binding activity in fully cytotoxic Shiga toxin 1.
11/2010	Shiga toxin 1 and ricin A chain bind to human polymorphonuclear leucocytes through a common receptor.
2/2006	Shiga toxins present in the gut and in the polymorphonuclear leukocytes circulating in the blood of children with hemolytic-uremic syndrome.
9/2004	Flow cytometry detection of Shiga toxins in the blood from children with hemolytic uremic syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Francesca Ricci Research Topics

Disease

31	Neoplasms (Cancer) 01/2022 - 01/2002
13	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2012 - 03/2005
11	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 07/2012
11	Infections 01/2020 - 09/2004
9	Hemolytic-Uremic Syndrome 01/2020 - 09/2004
8	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 05/2022 - 01/2017
8	Carcinoma (Carcinomatosis) 01/2022 - 01/2002
8	Waldenstrom Macroglobulinemia (Macroglobulinemia) 04/2013 - 03/2005
7	Leukemia 09/2014 - 04/2004
6	Hodgkin Disease (Hodgkin's Disease) 01/2022 - 03/2015
6	Acute Kidney Injury (Acute Renal Failure) 01/2020 - 02/2006
6	Residual Neoplasm 05/2018 - 05/2006
5	Inflammation (Inflammations) 07/2021 - 06/2011
5	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 09/2014 - 04/2009
5	Neoplasm Metastasis (Metastasis) 10/2013 - 12/2004
5	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2012 - 08/2008
4	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2022 - 03/2005
4	Lymphoma (Lymphomas) 01/2022 - 09/2006
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2012 - 11/2008
3	Newborn Respiratory Distress Syndrome 06/2022 - 01/2017
3	Lung Injury 06/2022 - 01/2020
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 12/2012
3	Ovarian Epithelial Carcinoma 01/2019 - 10/2013
3	Hematologic Neoplasms (Hematological Malignancy) 12/2013 - 09/2006
3	Myocardial Infarction 02/2013 - 01/2009
3	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2012 - 03/2009
3	Disease Progression 01/2012 - 12/2004
3	Paraproteinemias (Monoclonal Gammopathy) 02/2011 - 03/2005
3	Pancreatic Neoplasms (Pancreatic Cancer) 04/2006 - 12/2004
2	Pneumonia (Pneumonitis) 06/2022 - 12/2017
2	Hyperoxia 01/2022 - 01/2019
2	Thrombosis (Thrombus) 01/2022 - 10/2021
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2022 - 01/2022
2	Bronchopulmonary Dysplasia 01/2022 - 12/2017
2	COVID-19 12/2021 - 01/2021
2	Chronic Obstructive Pulmonary Disease (COPD) 07/2021 - 01/2021
2	Hypoxia (Hypoxemia) 12/2018 - 01/2014
2	Abdominal Aortic Aneurysm 01/2017 - 01/2015
2	Breast Neoplasms (Breast Cancer) 04/2016 - 01/2013
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 09/2015 - 08/2007
2	ST Elevation Myocardial Infarction 02/2013 - 12/2012
2	Ischemia 05/2011 - 03/2008
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 04/2011 - 07/2006

Drug/Important Bio-Agent (IBA)

11	fludarabineIBA 04/2013 - 05/2006
10	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2002
9	Biological ProductsIBA 12/2018 - 01/2002
7	Surface-Active Agents (Surfactants)IBA 06/2022 - 01/2017
7	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 12/2014
7	PlatinumIBA 01/2022 - 10/2013
7	Pharmaceutical PreparationsIBA 01/2019 - 01/2005
6	Shiga Toxins (Vero Toxin)IBA 01/2020 - 09/2004
5	Rituximab (Mabthera)FDA Link 01/2022 - 11/2010
5	DNA (Deoxyribonucleic Acid)IBA 10/2021 - 09/2006
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2013 - 03/2005
5	Alemtuzumab (Campath)FDA Link 10/2011 - 05/2006
4	poractant alfa (Curosurf)FDA Link 06/2022 - 01/2017
4	CytokinesIBA 06/2022 - 06/2011
4	Immune Checkpoint InhibitorsIBA 01/2022 - 06/2021
4	Shiga Toxin (Shigella Toxin)IBA 02/2016 - 09/2004
4	Immunoglobulin M (IgM)IBA 04/2013 - 03/2005
3	Messenger RNA (mRNA)IBA 06/2022 - 05/2018
3	GadoliniumIBA 01/2022 - 08/2020
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 09/2015
3	LigandsIBA 12/2021 - 11/2005
3	Therapeutic UsesIBA 07/2021 - 01/2011
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 10/2019
3	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 03/2008
3	MTOR InhibitorsIBA 09/2014 - 04/2009
3	TOR Serine-Threonine KinasesIBA 09/2014 - 04/2009
3	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 12/2012 - 04/2009
2	CHF5633IBA 06/2022 - 01/2017
2	Cytidine Triphosphate (CTP)IBA 01/2022 - 07/2020
2	NivolumabIBA 12/2021 - 06/2021
2	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2021 - 03/2005
2	Budesonide (Pulmicort)FDA LinkGeneric 07/2021 - 12/2017
2	AntioxidantsIBA 01/2020 - 08/2007
2	Pulmonary Surfactants (Pulmonary Surfactant)IBA 07/2019 - 01/2017
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2017 - 01/2012
2	Phosphatidylinositols (Phosphatidylinositol)IBA 04/2016 - 09/2014
2	Sirolimus (Rapamycin)FDA Link 12/2012 - 10/2010
2	Mechanistic Target of Rapamycin Complex 1IBA 08/2012 - 01/2012
2	Protein Kinases (Protein Kinase)IBA 07/2012 - 12/2004
2	Inosine Triphosphate (ITP)IBA 04/2011 - 07/2006
2	Immunoglobulins (Immunoglobulin)IBA 02/2011 - 03/2005
2	Alkylating AgentsIBA 01/2011 - 03/2009
2	Cytarabine (Cytosar-U)FDA LinkGeneric 10/2010 - 08/2009
2	purineIBA 03/2009 - 02/2009
2	Indicators and Reagents (Reagents)IBA 08/2008 - 09/2004

Therapy/Procedure

24	Therapeutics 01/2022 - 04/2006
8	Drug Therapy (Chemotherapy) 01/2022 - 11/2008
3	Continuous Positive Airway Pressure 01/2020 - 01/2017
3	Transplantation 12/2014 - 08/2008
3	Combination Drug Therapy (Combination Chemotherapy) 08/2012 - 03/2005
2	Immunotherapy 12/2021 - 12/2020
2	Salvage Therapy 06/2021 - 04/2013
2	Radiotherapy 06/2021 - 04/2004
2	Transcatheter Aortic Valve Replacement 03/2020 - 01/2019
2	Stem Cell Transplantation 01/2020 - 03/2015
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 02/2013 - 01/2011
2	Cardiac Rehabilitation 02/2013 - 12/2012